T-cell traffic jam in Hodgkin's lymphoma: Pathogenetic and therapeutic implications

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Fozza, Claudio ^a   Longinotti, Maurizio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HODGKIN DISEASE; HUMAN; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 78349290436     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/501659     Document Type: Review

References (80)

1. Rottino A., Hoffmann G. T., Studies of immunological reactions of patients with Hodgkin's disease: the tuberculin reaction The American Journal of the Medical Sciences 1950 220 6 662 664
2. Poppema S., The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease American Journal of Pathology 1989 135 2 351 357
3. Peh S. C., Kim L. H., Poppema S., TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma American Journal of Surgical Pathology 2001 25 7 925 929
4. Atayar., van den Berg A., Blokzijl T., Boot M., Gascoyne R. D., Visser L., Poppema S., Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments Journal of Clinical Pathology 2007 60 10 1092 1097
5. Lin P., Medeiros L. J., Wilder R. B., Abruzzo L. V., Manning J. T., Jones D., The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease Histopathology 2004 44 6 561 569
6. Nam-Cha S. H., Montes-Moreno S., Salcedo M. T., Sanjuan J., Garcia J. F., Piris M. A., Lymphocyte-rich classical hodgkin's lymphoma: distinctive tumor and microenvironment markers Modern Pathology 2009 22 8 1006 1015
7. lvaro-Naranjo T., Lejeune M., Salvad-Usach M. T., Bosch-Prncep R., Reverter-Branchat G., Jan-Martnez J., Pons-Ferr L. E., Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients Leukemia and Lymphoma 2005 46 11 1581 1591
8. Machado L., Jarrett R., Morgan S., Murray P., Hunter B., Hamilton E., Crocker J., Thomas W., Steven N., Ismail T., Chapman A., Adams D. H., Lee S. P., Expression and function of T cell homing molecules in Hodgkin's lymphoma Cancer Immunology, Immunotherapy 2009 58 1 85 94
9. Trmper L., Jung W., Daus H., Mechtersheimer G., von Bonin F., Pfreundschuh M., Assessment of clonality of rosetting T lymphocytes in Hodgkin's disease by single-cell polymerase chain reaction: detection of clonality in a polyclonal background in a case of lymphocyte predominance Hodgkin's disease Annals of Hematology 2001 80 11 653 661
10. Willenbrock K., Roers A., Blohbaum B., Rajewsky K., Hansmann M.-L., CD8 + T cells in Hodgkin's disease tumor tissue are a polyclonal population with limited clonal expansion but little evidence of selection by antigen American Journal of Pathology 2000 157 1 171 175
11. Franzke A., Koenecke C., Geffers R., Piao W., Hunger J. K., Ganser A., Buer J., Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes Tumor Biology 2006 27 6 329 333
12. Serrano D., Ghiotto F., Roncella S., Airoldi I., Cutrona G., Truini M., Burgio V. L., Baroni C. D., Ferrarini M., Pistoia V., The patterns of IL2, IFN-, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar Haematologica 1997 82 5 542 549
13. Poppema S., van den Berg A., Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas Seminars in Cancer Biology 2000 10 5 345 350
14. Gruss H.-J., Pinto A., Duyster J., Poppema S., Herrmann F., Hodgkin's disease: a tumor with disturbed immunological pathways Immunology Today 1997 18 4 156 163
15. Groux H., Bigler M., de Vries J. E., Roncarolo M.-G., Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells Journal of Experimental Medicine 1996 184 1 19 29 (Pubitemid 26247211)
16. Buri C., Krner M., Schrli P., Cefai D., Uguccioni M., Mueller C., Laissue J. A., Mazzucchelli L., CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease Blood 2001 97 6 1543 1548
17. Ohshima K., Tutiya T., Yamaguchi T., Suzuki K., Suzumiya J., Kawasaki C., Haraoka S., Kikuchi M., Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin disease: relation with expression of CXC and CC chemokines on HRS cells International Journal of Cancer 2002 98 4 567 572
18. Aldinucci D., Olivo K., Lorenzon D., Poletto D., Gloghini A., Carbone A., Pinto A., The role of interleukin-3 in classical Hodgkin's disease Leukemia and Lymphoma 2005 46 3 303 311
19. Cattaruzza L., Gloghini A., Olivo K., Di Francia R., Lorenzon D., De Filippi R., Carbone A., Colombatti A., Pinto A., Aldinucci D., Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma International Journal of Cancer 2009 125 5 1092 1101
20. Mainou-Fowler T., Taylor P. R. A., Miller S., Dickinson A. M., Proctor S. J., Intracellular cytokine profiles by peripheral blood CD3+ T-cells in patients with classical Hodgkin lymphoma Leukemia and Lymphoma 2003 44 8 1325 1331
21. Mainou-Fowler T., Proctor S. J., Taylor P. R. A., Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma Leukemia Research 2004 28 2 159 166
22. Juszczynski P., Ouyang J., Monti S., Rodig S. J., Takeyama K., Abramson J., Chen W., Kutok J. L., Rabinovich G. A., Shipp M. A., The AP1-dependent secretion of galectin-1 by Reed-Sternberg cells fosters immune privilege in classical Hodgkin lymphoma Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 13134 13139
23. Gandhi M. K., Moll G., Smith C., Dua U., Lambley E., Ramuz O., Gill D., Marlton P., Seymour J. F., Khanna R., Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma Blood 2007 110 4 1326 1329
24. Yamamoto R., Nishikori M., Kitawaki T., Sakai T., Hishizawa M., Tashima M., Kondo T., Ohmori K., Kurata M., Hayashi T., Uchiyama T., PD-1 PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma Blood 2008 111 6 3220 3224
25. Chemnitz J. M., Eggle D., Driesen J., Classen S., Riley J. L., Debey-Pascher S., Beyer M., Popov A., Zander T., Schultze J. L., RNA fingerprints provide direct evidence for the inhibitory role of TGF and PD-1 on CD4+ T cells in Hodgkin lymphoma Blood 2007 110 9 3226 3233
26. Muenst S., Hoeller S., Dirnhofer S., Tzankov A., Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival Human Pathology 2009 40 12 1715 1722
27. Steidl C., Lee T., Shah S. P., Farinha P., Han G., Nayar T., Delaney A., Jones S. J., Iqbal J., Weisenburger D. D., Bast M. A., Rosenwald A., Muller-Hermelink H. -K., Rimsza L. M., Campo E., Delabie J., Braziel R. M., Cook J. R., Tubbs R. R., Jaffe E. S., Lenz G., Connors J. M., Staudt L. M., Chan W. C., Gascoyne R. D., Tumor-associated macrophages and survival in classic Hodgkin's lymphoma New England Journal of Medicine 2010 362 10 875 885
28. Chemnitz J. M., Driesen J., Classen S., Riley J. L., Debey S., Beyer M., Popov A., Zander T., Schultze J. L., Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma Cancer Research 2006 66 2 1114 1122
29. Bosshart H., Levels of B7-2 in tumor cells of Hodgkin's disease Immunology Letters 2004 92 3 217 220
30. Oelmann E., Herbst H., Zhlsdorf M., Albrecht O., Nolte A., Schmitmann C., Manzke O., Diehl V., Stein H., Berdel W. E., Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Stemberg cells Blood 2002 99 1 258 267
31. Kosmaczewska A., Frydecka I., Boko D., Ciszak L., Teodorowska R., Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production British Journal of Haematology 2002 118 1 202 209
32. Su C.-C., Chiu H.-H., Chang C.-C., Chen J.-C., Hsu S.-M., CD30 Is Involved in Inhibition of T-Cell Proliferation by Hodgkin's Reed-Sternberg Cells Cancer Research 2004 64 6 2148 2152
33. Bladergroen B. A., Meijer C. J. L. M., Ten Berge R. L., Hack C. E., Muris J. J. F., Dukers D. F., Chott A., Kazama Y., Oudejans J. J., Van Berkum O., Kummer J. A., Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: A novel protective mechanism for tumor cells to circumvent the immune system? Blood 2002 99 1 232 237
34. Gasparri A. M., Jachetti E., Colombo B., Sacchi A., Curnis F., Rizzardi G.-P., Traversari C., Bellone M., Corti A., Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFN Molecular Cancer Therapeutics 2008 7 12 3859 3866
35. Yoshikawa T., Hara T., Tsurumi H., Goto N., Hoshi M., Kitagawa J., Kanemura N., Kasahara S., Ito H., Takemura M., Saito K., Seishima M., Takami T., Moriwaki H., Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP European Journal of Haematology 2010 84 4 304 309
36. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., Sakaguchi S., Thymus and autoimmunity: production of CD25 + CD4 + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance Journal of Immunology 1999 162 9 5317 5326
37. Hori S., Carvalho T. L., Demengeot J., CD25 + CD4 + regulatory T cells suppress CD4 + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice European Journal of Immunology 2002 32 5 1282 1291
38. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H., Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clinical Cancer Research 2003 9 12 4404 4408
39. Ehrenstein M. R., Evans J. G., Singh A., Moore S., Warnes G., Isenberg D. A., Mauri C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF therapy Journal of Experimental Medicine 2004 200 3 277 285
40. Marshall N. A., Christie L. E., Munro L. R., Culligan D. J., Johnston P. W., Barker R. N., Vickers M. A., Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 2004 103 5 1755 1762
41. lvaro T., Lejeune M., Salvad MA. T., Bosch R., Garca J. F., Jan J., Banham A. H., Roncador G., Montalbn C., Piris M. A., Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells Clinical Cancer Research 2005 11 4 1467 1473
42. Kelley T. W., Pohlman B., Elson P., Hsi E. D., The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression American Journal of Clinical Pathology 2007 128 6 958 965
43. Tzankov A., Meier C., Hirschmann P., Went P., Pileri S. A., Dirnhofer S., Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma Haematologica 2008 93 2 193 200
44. Koreishi A. F., Saenz A. J., Persky D. O., Cui H., Moskowitz A., Moskowitz C. H., Teruya-Feldstein J., The role of cytotoxic and regulatory T cells in relapsed/refractory hodgkin lymphoma Applied Immunohistochemistry and Molecular Morphology 2010 18 3 206 211
45. Schreck S., Friebel D., Buettner M., Distel L., Grabenbauer G., Young L. S., Niedobitek G., Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin Lymphoma Hematological Oncology 2009 27 1 31 39
46. Ishida T., Ishii T., Inagaki A., Yano H., Komatsu H., Iida S., Inagaki H., Ueda R., Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege Cancer Research 2006 66 11 5716 5722
47. Lamprecht B., Kreher S., Anagnostopoulos I., Jhrens K., Monteleone G., Jundt F., Stein H., Janz M., Drken B., Mathas S., Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3{alpha} Blood 2008 112 8 3339 3347
48. Baumforth K. R. N., Birgersdotter A., Reynolds G. M., Wei W., Kapatai G., Flavell J. R., Kalk E., Piper K., Lee S., Machado L., Hadley K., Sundblad A., Sjoberg J., Bjorkholm M., Porwit A. A., Yap L.-F., Teo S., Grundy R. G., Young L. S., Ernberg I., Woodman C. B. J., Murray P. G., Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells American Journal of Pathology 2008 173 1 195 204
49. Gandhi M. K., Lambley E., Duraiswamy J., Dua U., Smith C., Elliott S., Gill D., Marlton P., Seymour J., Khanna R., Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients Blood 2006 108 7 2280 2289
50. Tanijiri T., Shimizu T., Uehira K., Yokoi T., Amuro H., Sugimoto H., Torii Y., Tajima K., Ito T., Amakawa R., Fukuhara S., Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4 + CD25 + Foxp3 + T cells and CD4 + cytotoxic T lymphocytes from CD4 + naive T cells Journal of Leukocyte Biology 2007 82 3 576 584
51. Bosler D. S., Douglas-Nikitin V. K., Harris V. N., Smith M. D., Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma Cytometry Part B 2008 74 4 227 235
52. Barth S., Aleksza M., Keresztes K., Tth J., Sipka S., Szegedi G., Ills., Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma Acta Haematologica 2006 116 3 181 185 (Pubitemid 44532962)
53. Ma Y., Visser L., Blokzijl T., Harms G., Atayar., Poppema S., van den Berg A., The CD4+CD26 T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile Laboratory Investigation 2008 88 5 482 490
54. Peggs K. S., Hunter A., Chopra R., Parker A., Mahendra P., Milligan D., Craddock C., Pettengell R., Dogan A., Thomson K. J., Morris E. C., Hale G., Waldmann H., Goldstone A. H., Linch D. C., MacKinnon S., Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation Lancet 2005 365 9475 1934 1941
55. Di Stasi A., De Angelis B., Rooney C. M., Zhang L., Mahendravada A., Foster A. E., Heslop H. E., Brenner M. K., Dotti G., Savoldo B., T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model Blood 2009 113 25 6392 6402
56. Kashkar H., Seeger J.-M., Hombach A., Deggerich A., Yazdanpanah B., Utermhlen O., Heimlich G., Abken H., Krnke M., XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack Blood 2006 108 10 3434 3440
57. Frydecka I., Bocko D., Kosmaczewska A., Ciszak L., Morilla R., The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease British Journal of Cancer 2001 84 10 1339 1343
58. Heuser C., Diehl V., Abken H., Hombach A., Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN- secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells International Journal of Cancer 2003 106 4 545 552
59. Heuser C., Guhlke S., Matthies A., Bender H., Barth S., Diehl V., Abken H., Hombach A., Anti-CD30-scFV-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells International Journal of Cancer 2004 110 3 386 394
60. Bollard C. M., Rssig C., Julia Calonge M., Helen Huls M., Wagner H.-J., Massague J., Brenner M. K., Heslop H. E., Rooney C. M., Adapting a transforming growth factor -related tumor protection strategy to enhance antitumor immunity Blood 2002 99 9 3179 3187
61. Lacuesta K., Buza E., Hauser H., Granville L., Pule M., Corboy G., Finegold M., Weiss H., Chen S. Y., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor- receptor Journal of Immunotherapy 2006 29 3 250 260
62. Foster A. E., Dotti G., Lu A., Khalil M., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF- receptor Journal of Immunotherapy 2008 31 5 500 505
63. Shafer J. A., Cruz C. R., Leen A. M., Ku S., Lu A., Rousseau A., Heslop H. E., Rooney C. M., Bollard C. M., Foster A. E., Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma Leukemia and Lymphoma 2010 51 5 870 880
64. Buglio D., Georgakis G. V., Hanabuchi S., Arima K., Khaskhely N. M., Liu Y.-J., Younes A., Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines Blood 2008 112 4 1424 1433
65. Leemhuis T., Wells S., Scheffold C., Edinger M., Negrin R. S., A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma Biology of Blood and Marrow Transplantation 2005 11 3 181 187
66. Kandil A., Bazarbashi S., Mourad W. A., The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease Cancer 2001 91 11 1957 1963
67. Rickinson A. B., Moss D. J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection Annual Review of Immunology 1997 15 405 431
68. Diepstra A., Niens M., Vellenga E., Van Imhoff G. W., Nolte I. M., Schaapveld M., Van Der Steege G., van den Berg A., Kibbelaar R. E., Te Meerman G. J., Poppema S., Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma Lancet 2005 365 9478 2216 2224
69. Hjalgrim H., Rostgaard K., Johnson P. C. D., Shield L., Little A. -M., Ekstrom-Smedby K., Adami H. -O., Glimelius B., Hamilton-Dutoit S., Kane E., Malcolm Taylor G., McConnachie A., Ryder L. P., Sundstrom C., Andersen P. S., Chang E. T., Alexander F. E., Melbye M., Jarrett R. F., HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma Proceedings of the National Academy of Sciences of the United States of America 2010 107 14 6400 6405
70. Wilson W. M., Dua U., Grigg A. P., Gandhi M. K., Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma Leukemia and Lymphoma 2006 47 5 871 876
71. Chapman A. L. N., Rickinson A. B., Thomas W. A., Jarrett R. F., Crocker J., Lee S. P., Epstein-barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: Implications for a T-cell-based therapy Cancer Research 2001 61 16 6219 6226
72. Kohrt H., Johannsen A., Hoppe R., Horning S. J., Rosenberg S. A., Advani R., Lee P. P., Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease Oncology Research 2009 18 5-6 287 292
73. Rooney C. M., Bollard C., Huls M. H., Gahn B., Gottschalk ST., Wagner H. J., Anderson R., Prentice H. G., Brenner M. K., Heslop H. E., Immunotherapy for Hodgkin's disease Annals of Hematology 2002 81 2 S39 S42
74. Bollard C. M., Straathof K. C. M., Huls M. H., Leen A., Lacuesta K., Davis A., Gottschalk S., Brenner M. K., Heslop H. E., Rooney C. M., The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease Journal of Immunotherapy 2004 27 4 317 327
75. Bollard C. M., Aguilar L., Straathof K. C., Gahn B., Huls M. H., Rousseau A., Sixbey J., Gresik M. V., Carrum G., Hudson M., Dilloo D., Gee A., Brenner M. K., Rooney C. M., Heslop H. E., Cytotoxic T lymphocyte therapy for epstein-barr virus+ Hodgkin's disease Journal of Experimental Medicine 2004 200 12 1623 1633
76. Bollard C. M., Gottschalk S., Leen A. M., Weiss H., Straathof K. C., Carrum G., Khalil M., Wu M.-F., Huls M. H., Chang C.-C., Gresik M. V., Gee A. P., Brenner M. K., Rooney C. M., Heslop H. E., Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood 2007 110 8 2838 2845
77. Lucas K. G., Salzman D., Garcia A., Sun Q., Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease Cancer 2004 100 9 1892 1901
78. Wagner H.-J., Bollard C. M., Vigouroux S., Huls M. H., Anderson R., Prentice H. G., Brenner M. K., Heslop H. E., Rooney C. M., A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells Cancer Gene Therapy 2004 11 2 81 91
79. Smith C., Cooper L., Burgess M., Rist M., Webb N., Lambley E., Tellam J., Marlton P., Seymour J. F., Gandhi M., Khanna R., Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope Journal of Immunology 2006 177 7 4897 4906
80. Savoldo B., Rooney C. M., Di Stasi A., Abken H., Hombach A., Foster A. E., Zhang L., Heslop H. E., Brenner M. K., Dotti G., Epstein Barr virus-specific cytotoxic T lymphocytes expressing the anti-CD30 artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease Blood 2007 110 7 2620 2630